Drug
Epo 018b
Epo 018b: highest development phase Phase 2, developed by Hansoh Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| EPO-018B NCT02366325 | Phase 2 | Chronic Renal Failure |
Latest
No recent events.
Follow Epo 018b on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.